vida: research 2026 04 28 #4803

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 11:04:41 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 11:05 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 11:05 UTC*
Member
  1. Factual accuracy — The claims in the research-journal.md file regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and align with general market trends in the GLP-1 space.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content in research-journal.md is unique, and the inbox/queue files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry details specific commercial outcomes (bankruptcy vs. profitable IPO) that strongly support the "atoms-to-bits" thesis, justifying the "SIGNIFICANTLY STRENGTHENED" assessment.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the `research-journal.md` file regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and align with general market trends in the GLP-1 space. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content in `research-journal.md` is unique, and the `inbox/queue` files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry details specific commercial outcomes (bankruptcy vs. profitable IPO) that strongly support the "atoms-to-bits" thesis, justifying the "SIGNIFICANTLY STRENGTHENED" assessment. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes.

2. Duplicate/redundancy:
This is a research journal entry documenting a new investigation session (2026-04-28) with nine new source files queued for future claim extraction — no claims are being enriched or created in this PR, so no redundancy issues exist.

3. Confidence:
No claims are present in this PR (only research journal documentation and queued sources), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken claim links — no actual wiki link syntax is used, so no broken links exist.

5. Source quality:
Nine sources are queued in inbox/queue/ covering WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, and payer behavioral mandates — these appear to be substantive market events and company announcements appropriate for healthcare market analysis, though I cannot verify URLs from the diff alone.

6. Specificity:
No claims are present in this PR to evaluate for specificity — this is purely research documentation that will inform future claim creation.

Additional observations:
The research journal entry documents a disconfirmation attempt of "Belief 4" that instead strengthened the belief through the WeightWatchers bankruptcy vs. Omada IPO natural experiment — this is methodologically sound research practice (attempting falsification) and the queued sources appear positioned to support future claim extraction about atoms-to-bits defensibility in healthcare behavioral support markets.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes. **2. Duplicate/redundancy:** This is a research journal entry documenting a new investigation session (2026-04-28) with nine new source files queued for future claim extraction — no claims are being enriched or created in this PR, so no redundancy issues exist. **3. Confidence:** No claims are present in this PR (only research journal documentation and queued sources), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken claim links — no actual [[wiki link]] syntax is used, so no broken links exist. **5. Source quality:** Nine sources are queued in inbox/queue/ covering WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, and payer behavioral mandates — these appear to be substantive market events and company announcements appropriate for healthcare market analysis, though I cannot verify URLs from the diff alone. **6. Specificity:** No claims are present in this PR to evaluate for specificity — this is purely research documentation that will inform future claim creation. **Additional observations:** The research journal entry documents a disconfirmation attempt of "Belief 4" that instead strengthened the belief through the WeightWatchers bankruptcy vs. Omada IPO natural experiment — this is methodologically sound research practice (attempting falsification) and the queued sources appear positioned to support future claim extraction about atoms-to-bits defensibility in healthcare behavioral support markets. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 11:06:27 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 11:06:28 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 11:08:29 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.